Status:

NOT_YET_RECRUITING

HIIT in Isolated IFG: A Proof-of-Concept Study

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Center for Advancing Translational Sciences (NCATS)

Conditions:

Isolated Impaired Fasting Glucose

Eligibility:

All Genders

35-65 years

Phase:

NA

Brief Summary

This pilot randomized controlled trial will involve 34 physically inactive adults aged 35-65 years with overweight or obesity and isolated impaired fasting glucose (i-IFG). The study aims to assess th...

Detailed Description

This 1:1 proof-of-concept randomized controlled trial (RCT) will involve 34 physically inactive adults aged 35-65 years who are overweight or obese and have isolated impaired fasting glycemia (i-IFG)....

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Males and females aged 35-65 years
  • Any race or ethnicity
  • BMI ≥25 kg/m2 (≥23 kg/m2 if Asian decent)
  • Physically inactive (\<150 min of moderate-intensity or \<75 min of vigorous-intensity aerobic physical activity/week)
  • Will be residing in the same location until completion of the study
  • Isolated impaired fasting glucose on the OGTT: FPG 100-125 mg/dl and 2-hr plasma glucose \<140 mg/dl
  • Exclusion criteria:
  • History of diabetes
  • Regular exercise training in the past 6 months
  • Enrolled in weight loss programs in the past 6 months
  • Following a specific diet (e.g., ketogenic, Mediterranean)
  • Pregnant women
  • Breastfeeding
  • Smokers
  • Taking medications known to affect glucose tolerance (e.g., steroids)
  • Taking beta-blockers and calcium channel blockers
  • Taking weight loss medications
  • Underwent bariatric surgery
  • Anemia
  • History of chronic illnesses (e.g., stroke)
  • Individuals satisfying the eligibility criteria will undergo an OGTT (0, 30, 120 min), and those diagnosed with i-IFG (FPG 100 or 110-125 mg/dl and 2-hr PG \<140 mg/dl) will be recruited to the study.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2026

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 30 2026

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT06143345

    Start Date

    June 1 2026

    End Date

    December 30 2026

    Last Update

    January 9 2026

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.